These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26669756)

  • 1. MCO Membranes: Enhanced Selectivity in High-Flux Class.
    Boschetti-de-Fierro A; Voigt M; Storr M; Krause B
    Sci Rep; 2015 Dec; 5():18448. PubMed ID: 26669756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
    Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
    Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded haemodialysis: from operational mechanism to clinical results.
    Ronco C; Marchionna N; Brendolan A; Neri M; Lorenzin A; Martínez Rueda AJ
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii41-iii47. PubMed ID: 30281134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
    Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
    PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Internal Filtration in Hollow Fiber Hemodialyzers with Medium Cut-Off Membrane.
    Lorenzin A; Neri M; Lupi A; Todesco M; Santimaria M; Alghisi A; Brendolan A; Ronco C
    Blood Purif; 2018; 46(3):196-204. PubMed ID: 29886489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic Toxins: how can we improve the removal today?].
    Teatini U; Romei Longhena G
    G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended characterization of a new class of membranes for blood purification: the high cut-off membranes.
    Boschetti-de-Fierro A; Voigt M; Storr M; Krause B
    Int J Artif Organs; 2013 Jul; 36(7):455-63. PubMed ID: 23661558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Innovation in Dialysis.
    Boschetti-de-Fierro A; Beck W; Hildwein H; Krause B; Storr M; Zweigart C
    Contrib Nephrol; 2017; 191():100-114. PubMed ID: 28910794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
    Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
    Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evolving Patterns of Uremia: Unmet Clinical Needs in Dialysis.
    Yu X
    Contrib Nephrol; 2017; 191():1-7. PubMed ID: 28910786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
    Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
    Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of new hemodialysis membranes and equipment.
    Vanholder R; Glorieux G; Van Biesen W
    Nephron Clin Pract; 2010; 114(3):c165-72. PubMed ID: 19955821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional Classification of Dialysis Membranes.
    Ronco C; Neri M; Lorenzin A; Garzotto F; Clark WR
    Contrib Nephrol; 2017; 191():115-126. PubMed ID: 28910795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study.
    Dominik A; Stange J; Pfensig C; Borufka L; Weiss-Reining H; Eggert M
    Ther Apher Dial; 2014 Aug; 18(4):347-52. PubMed ID: 24215331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rise of Expanded Hemodialysis.
    Ronco C
    Blood Purif; 2017; 44(2):I-VIII. PubMed ID: 28486230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruptive technologies for hemodialysis: medium and high cutoff membranes. Is the future now?
    Reis T; Anwar S; Neves FADR; Ronco C
    J Bras Nefrol; 2021; 43(3):410-416. PubMed ID: 33836041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
    Herič T; Vivoda T; Bogataj Š; Pajek J
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.
    Van Biesen W; Vanholder R; Schepers E; Glorieux G; Dhondt A; Eloot S
    Contrib Nephrol; 2017; 191():168-177. PubMed ID: 28910800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.